SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NPCE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 66.09M
March 31, 2026 67.05M
December 31, 2025 65.67M
September 30, 2025 64.14M
June 30, 2025 60.86M
March 31, 2025 57.05M
December 31, 2024 57.10M
September 30, 2024 56.53M
June 30, 2024 56.01M
March 31, 2024 56.19M
December 31, 2023 54.52M
September 30, 2023 54.87M
June 30, 2023 54.04M
Date Value
March 31, 2023 52.32M
December 31, 2022 51.34M
September 30, 2022 49.51M
June 30, 2022 46.38M
March 31, 2022 43.14M
December 31, 2021 38.96M
September 30, 2021 27.22M
June 30, 2021 24.84M
March 31, 2021 20.93M
December 31, 2020 20.35M
September 30, 2020 20.35M
June 30, 2020 13.30M
March 31, 2020 7.682M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Tandem Diabetes Care, Inc. 441.37M
CVRx, Inc. 89.46M
Accuray, Inc. 86.17M
Micron Solutions, Inc. --
Orthofix Medical, Inc. 557.80M